Related Experiment Video

Updated: Oct 21, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastastic potential

A Turco1, A Coppa, S Aloe

  • 1Dipartimento di Scienze e Tecnologie Biomediche, Università dell'Aquila, Italy.

International Journal of Cancer
|February 6, 1999
PubMed

Insights

Overexpressing the transforming growth factor beta receptor type II (TbetaRII) gene suppressed tumor growth and metastasis in malignant thyroid cells. This finding highlights TbetaRII

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Transforming growth factor beta receptor type II (TbetaRII) expression is crucial for inhibiting thyroid epithelial cell growth.
  • Reduced TbetaRII expression is linked to resistance to TGF-beta and observed in various human thyroid carcinomas.
  • The role of TbetaRII in modulating the tumorigenic potential of k-ras-transformed thyroid cells requires further investigation.

Purpose of the Study:

  • To investigate the role of TbetaRII in modulating the tumorigenic potential of k-ras-transformed thyroid cells.
  • To determine if TbetaRII overexpression can suppress the malignant phenotype of thyroid cancer cells.

Main Methods:

  • Transfection of k-ras-transformed rat thyroid cells with a human TbetaRII gene expression vector under an inducible promoter.
  • Assessment of anchorage-dependent and -independent cell growth in transfected clones.
  • Evaluation of tumorigenicity and metastasis in athymic nude mice models.

Main Results:

  • TbetaRII-overexpressing clones exhibited reduced anchorage-dependent and -independent cell growth compared to controls.
  • Transfected clones showed decreased tumorigenicity when transplanted into athymic nude mice.
  • A statistically significant reduction in spontaneous and lung metastases was observed in TbetaRII-overexpressing clones.

Conclusions:

  • TbetaRII acts as a potent tumor suppressor gene in malignant thyroid cells.
  • Overexpression of TbetaRII can significantly inhibit thyroid cancer cell growth, tumorigenicity, and metastatic potential.
  • Restoring TbetaRII expression may represent a therapeutic strategy for thyroid cancer.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...